Thought Leader Select delivers KOL identification research to five leading pharma companies in the U.S. and Canada
April 14, 2010 · Leave a comment
April 15, 2010 (CHAPEL HILL, NC)—Thought Leader Select, a North Carolina-based firm dedicated to delivering solutions for key opinion leader (KOL) management for the biopharmaceutical industry, has announced the delivery of KOL identification projects for five leading North American pharmaceutical companies during the first quarter of 2010.
Five of the world’s largest pharmaceutical concerns contracted with Thought Leader Select in late 2009 to take advantage of the firm’s industry-leading deep profiling methodology for researching the skills and experiences of physician key opinion leaders across multiple therapeutic areas and disease states. Each company had specialized needs for initiation and redevelopment of their respective rosters of key opinion leaders to assist them in a variety of deployment needs.
Thought Leader Select assisted a Canadian firm with the identification of physician key opinion leaders who specialize in influenza vaccines. The company plans to build a firm roster of KOLs in advance of a new influenza vaccine product launch.
A U.S. firm contracted Thought Leader Select to identify nurse practitioners and physician assistants, also known as non-traditional KOLs, in the therapeutic areas of gastroenterology, hepatology, and HIV/AIDS treatment, in order to better understand patient needs in these areas and gain scientific and clinical insights for new compounds.
Thought Leader Select identified Canadian physician key opinion leaders for another Canadian company, with emphasis on KOLs who specialize in heart ... read more »